Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
J-INSPIRE postmarketing surveillance of Darvadstrocel in complex perianal fistulas in Crohn's disease
jRCT2033210424Recruiting
- Sponsor
- Takeda
- Start
- Nov 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of darvadstrocel in Crohn's disease and anal fistula, sponsored by Takeda. Primary endpoints: Number of participants with adverse events, Percentage of participants who achieve clinical response and 2 more. Started Nov 2021; status: recruiting.
02
Drugs
darvadstrocel
03
Conditions
Crohn's diseaseanal fistula
Beyond the preview
Go deeper on jRCT2033210424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033210424.